596817-39-9 Usage
Description
(1-PYRIMIDIN-4-YL-PIPERIDIN-4-YL)-CARBAMIC ACID TERT-BUTYL ESTER is a chemical compound characterized by a pyrimidine ring fused to a piperidine ring, with a carbamic acid tert-butyl ester attached to the nitrogen atom of the piperidine ring. This unique structure endows it with potential bioactivity and medicinal properties, making it a valuable building block in drug discovery and development.
Used in Medicinal Chemistry:
(1-PYRIMIDIN-4-YL-PIPERIDIN-4-YL)-CARBAMIC ACID TERT-BUTYL ESTER is used as a starting material for the synthesis of novel chemical entities with potential therapeutic applications. Its unique structure and the tert-butyl ester group provide stability and protection, making it suitable for various synthetic and biological applications.
Used in Pharmaceutical Research:
In the pharmaceutical industry, (1-PYRIMIDIN-4-YL-PIPERIDIN-4-YL)-CARBAMIC ACID TERT-BUTYL ESTER is utilized for its potential bioactivity, serving as a key component in the development of new drugs with therapeutic benefits. Its versatility and value in medicinal chemistry contribute to advancing drug discovery and innovation.
Check Digit Verification of cas no
The CAS Registry Mumber 596817-39-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,9,6,8,1 and 7 respectively; the second part has 2 digits, 3 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 596817-39:
(8*5)+(7*9)+(6*6)+(5*8)+(4*1)+(3*7)+(2*3)+(1*9)=219
219 % 10 = 9
So 596817-39-9 is a valid CAS Registry Number.
596817-39-9Relevant articles and documents
FUSED MORPHLINOPYRIMIDINES AND METHODS OF USE THEREOF
-
Paragraph 0266, (2015/05/19)
The present invention relates to Fused Morpholinopyrimidines, pharmaceutical compositions comprising an effective amount of a Fused Morpholinopyrimidine and methods for using a Fused Morpholinopyrimidine in the treatment of a neurodegenerative disease, comprising administering to a subject in need thereof an effective amount of a Fused Morpholinopyrimidine.
Novel factor Xa inhibitors based on a 2-carboxyindole scaffold: SAR of P4 substituents in combination with a neutral P1 ligand
Nazare, Marc,Essrich, Melanie,Will, David W.,Matter, Hans,Ritter, Kurt,Urmann, Matthias,Bauer, Armin,Schreuder, Herman,Czech, Joerg,Lorenz, Martin,Laux, Volker,Wehner, Volkmar
, p. 4197 - 4201 (2007/10/03)
A series of novel, highly potent 2-carboxyindole-based factor Xa inhibitors is described. Structural requirements for P4 ligands in combination with a neutral biaryl P1 ligand were investigated with the 2-carboxyindole scaffold. A diverse set of P4 substituents was identified, which, in conjunction with a biaryl P1 ligand, gave highly potent factor Xa inhibitors, which were also selective versus other proteases and efficacious in various antithrombotic secondary assays.
NEW COMPOUNDS
-
Page/Page column 33, (2008/06/13)
The present invention relates to new, potent DPP-IV enzyme inhibitors of the general formula (I), which contain fluorine atoms.
